Publications by authors named "Mark Feitelson"

Claim this Profile
V
VDAC2 and Bak scarcity in liver mitochondria enables targeting hepatocarcinoma while sparing hepatocytes.
Shamim Naghdi, Piyush Mishra, Soumya Sinha Roy, David Weaver, Ludivine Walter, Mark A Feitelson

Nat Commun· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
TMEM43 promotes the development of hepatocellular carcinoma by activating VDAC1 through USP7 deubiquitination.
Nannan Zhang, Feiran Wang, Xiaobing Yang, Quhui Wang, Renan Chang, Mark A Feitelson

Transl Gastroenterol Hepatol· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Short-chain fatty acids in cancer pathogenesis.
Mark A Feitelson, Alla Arzumanyan, Arvin Medhat, Ira Spector

Cancer Metastasis Rev· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Editorial: Microbiome metabolites in health and disease.
Emanuel E Canfora, Mark A Feitelson, Alla Arzumanyan

Front Microbiol· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hepatitis B x (HBx) as a Component of a Functional Cure for Chronic Hepatitis B.
Mark A Feitelson, Alla Arzumanyan, Ira Spector, Arvin Medhat

Biomedicines· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hepatitis B x antigen (HBx) is an important therapeutic target in the pathogenesis of hepatocellular carcinoma.
Arvin Medhat, Alla Arzumanyan, Mark A Feitelson

Oncotarget· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Short chain fatty acids delay the development of hepatocellular carcinoma in HBx transgenic mice.
Noreen McBrearty, Alla Arzumanyan, Eugene Bichenkov, Salim Merali, Carmen Merali, Mark Feitelson

Neoplasia· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Studies on the Efficacy, Potential Cardiotoxicity and Monkey Pharmacokinetics of GLP-26 as a Potent Hepatitis B Virus Capsid Assembly Modulator.
Selwyn J Hurwitz, Noreen McBrearty, Alla Arzumanyan, Eugene Bichenkov, Sijia Tao, Mark A Feitelson

Viruses· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sustained proliferation in cancer: Mechanisms and novel therapeutic targets.
Mark A Feitelson, Alla Arzumanyan, Rob J Kulathinal, Stacy W Blain, Randall F Holcombe

Semin Cancer Biol· December 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Designing a broad-spectrum integrative approach for cancer prevention and treatment.
Keith I Block, Charlotte Gyllenhaal, Leroy Lowe, Amedeo Amedei, A R M Ruhul Amin, Mark A Feitelson

Semin Cancer Biol· December 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The roles of hepatitis B virus-encoded X protein in virus replication and the pathogenesis of chronic liver disease.
Mark A Feitelson, Barbara Bonamassa, Alla Arzumanyan

Expert Opin Ther Targets· March 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Human viral oncogenesis: a cancer hallmarks analysis.
Enrique A Mesri, Mark A Feitelson, Karl Munger

Cell Host Microbe· March 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Epigenetic regulation of MicroRNA-122 by peroxisome proliferator activated receptor-gamma and hepatitis b virus X protein in hepatocellular carcinoma cells.
Kyoungsub Song, Chang Han, Jinqiang Zhang, Dongdong Lu, Srikanta Dash, Mark Feitelson

Hepatology· November 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preclinical characterization of GLS4, an inhibitor of hepatitis B virus core particle assembly.
Guoyi Wu, Bo Liu, Yingjun Zhang, Jing Li, Alla Arzumanyan, Mark A Feitelson

Antimicrob Agents Chemother· November 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A spiroligomer α-helix mimic that binds HDM2, penetrates human cells and stabilizes HDM2 in cell culture.
Zachary Z Brown, Kavitha Akula, Alla Arzumanyan, Jennifer Alleva, Marcus Jackson, Mark A Feitelson

PLoS One· April 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
UCN-01 induces S and G2/M cell cycle arrest through the p53/p21(waf1) or CHK2/CDC25C pathways and can suppress invasion in human hepatoma cell lines.
Guoyi Wu, Nan Lin, Linan Xu, Bo Liu, Mark A Feitelson

BMC Cancer· March 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pathogenic mechanisms in HBV- and HCV-associated hepatocellular carcinoma.
Alla Arzumanyan, Helena M G P V Reis, Mark A Feitelson

Nat Rev Cancer· February 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of single and combination therapies with tenofovir disoproxil fumarate and emtricitabine in vitro and in a robust mouse model supporting high levels of hepatitis B virus replication.
Raymond F Schinazi, Leda Bassit, Marcia M Clayton, Bill Sun, James J Kohler, Mark A Feitelson

Antimicrob Agents Chemother· December 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Application of HBx-induced anti-URGs as early warning biomarker of cirrhosis and HCC.
Wen Wang, Lan-Juan Zhao, Yan Wang, Qing-Yuan Tao, Mark A Feitelson

Cancer Biomark· November 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hedgehog signaling blockade delays hepatocarcinogenesis induced by hepatitis B virus X protein.
Alla Arzumanyan, Vaishnavi Sambandam, Marcia M Clayton, Steve S Choi, Guanhua Xie, Mark A Feitelson

Cancer Res· November 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Role of miR-148a in hepatitis B associated hepatocellular carcinoma.
Ke Yuan, Zhaorui Lian, Bill Sun, Marcia M Clayton, Irene O L Ng, Mark A Feitelson

PLoS One· August 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adenoviral-mediated RNA interference targeting URG11 inhibits growth of human hepatocellular carcinoma.
Rui Fan, Xiaohua Li, Wenqi Du, Xue Zou, Rui Du, Mark A Feitelson

Int J Cancer· June 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Does the hepatitis B antigen HBx promote the appearance of liver cancer stem cells?
Alla Arzumanyan, Tiffany Friedman, Irene O L Ng, Marcia M Clayton, Zhaorui Lian, Mark A Feitelson

Cancer Res· May 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tupaia CD81, SR-BI, claudin-1, and occludin support hepatitis C virus infection.
Yimin Tong, Yongzhe Zhu, Xueshan Xia, Yuan Liu, Yue Feng, Mark A Feitelson

J Virol· March 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Oxidative stress and antioxidants in hepatic pathogenesis.
Hye-Lin Ha, Hye-Jun Shin, Mark A Feitelson, Dae-Yeul Yu

World J Gastroenterol· December 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis